The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

Columnist Candace Semien considers the rules, both written and unspoken, about how to maintain a healthy patient-doctor relationship.

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 for lupus.

Columnist Candace Semien is putting her body on a performance improvement plan so that she handles the Job of Life as best she can.

The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).

As we flip the page to a new year, the pull of hustle culture on social media hasn’t seemed to change. Messages urge us to do more, achieve more, and push harder. But for those of us living with lupus ...

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

Columnist Marisa Zeppieri has learned that taking a rest with lupus can be necessary and shouldn't cause guilt.

Lupkynis has been approved in Japan to treat lupus nephritis, when given alongside the immunosuppressant mycophenolate mofetil.

Patient screening has begun in the Ntrust-1 clinical trial of NKX019, a potential CAR cell therapy for treatment-resistant lupus nephritis.